BlackRock, Inc. Increases Stake in Chemours Company to 14.3%

BlackRock, Inc. has filed a Schedule 13G/A (Amendment No. 15) with the SEC, reporting a significant increase in its holdings of Chemours Company (CC) common stock. As of March 31, 2026, BlackRock beneficially owns 21,484,477 shares, representing 14.3% of the company's outstanding common stock. This is a substantial rise from the previously reported 0.0% ownership, indicating a major accumulation of shares. Of the total shares held, BlackRock has sole voting power over 21,244,817 shares and sole dispositive power over all 21,484,477 shares. The filing notes that the iShares Core S&P Small-Cap ETF specifically holds an interest exceeding 5% of the issuer's total outstanding common stock. The acquisition was made in the ordinary course of business and not with the intent to change or influence the control of the issuer. BlackRock operates as a parent holding company for various reporting business units that manage these securities.